Sign up for our complimentary
weekly e-journal

 
Bookmark and Share | Print | Category | Home Previous | All Articles This Week | Next
This article originally posted 23 November, 2009 and appeared in  Issue 497

HbA1c Levels Predict Carotid IMT in Adolescents with Diabetes

Higher HbA1c levels predict greater carotid intima-media thickness (IMT) in children and adolescents with Type 2 diabetes, new research shows.

Advertisement

Dr. Elaine M. Urbina, from the Cincinnati Children's Hospital Medical Center in Ohio stated that, "Now we have clear evidence in these adolescents that they're already developing target organ damage."

"This has been demonstrated in adults but this is really novel to demonstrate in such a young age group," Dr. Urbina added. "This is information that we need to use as physician advocates to really work with the legislature to improve reimbursement for obesity treatment."

In their published report, Dr. Urbina, Dr. Amy S. Shah and their colleagues note that most data on the evolution of atherosclerosis in young people is from autopsy studies. To learn more about the development of atherosclerosis in younger individuals and to identify risk factors, the researchers studied 129 patients of mixed ethnicity, ages 10 to 23, with Type 2 diabetes.

According to their report, 13.4% had an elevated common carotid IMT, 16.5% had increased bulb IMT, and 18.9% had elevated internal carotid IMT.

As HbA1c levels increased, the researchers found, so did study participants' carotid IMT. Duration of diabetes also was independently associated with carotid IMT.

For every 1% increase in HbA1c, the likelihood of having a thicker common carotid IMT increased by 35%, after adjustment for sex, systolic blood pressure z-score, and insulin use.

Furthermore, for every additional year of diabetes duration, the risk of a thicker bulb IMT rose by 33%, after adjustment for systolic blood pressure z score and HDL cholesterol, and the risk of a thicker internal carotid IMT rose by 29%, after controlling for sex, cholesterol levels and tumor necrosis factor alpha levels.

"These data suggest that poor glycemic control is associated with structural changes in the carotid artery that are consistent with early atherosclerosis," the researchers write.

Dr. Urbina wrote, "We suspect that these changes are reversible at this age.... There is evidence that thickening of the carotid artery wall in younger people consists of more fatty buildup and less calcification.... We suspect that these lesions are reversible, but we need more study."

J Clin Endocrinol Metab 2009;94:3740-3745.

 

 

Bookmark and Share | Print | Category | Home

This article originally posted 23 November, 2009 and appeared in  Issue 497

Past five issues: Issue 537 | Issue 536 | Issue 535 | Issue 534 | Issue 533 |

Recent Most Read Articles:

Obesity Reduces Survival By 2 Years
Posted March 31, 2009
Not Enough Sleep Causes More Eating and Diabetes Risk
Posted May 01, 2009
Test Your Knowledge Issue 469
Posted May 19, 2009
Generex Biotechnology Announces Successful Phase III Study Data for Generex Oral-lyn(tm)
Posted March 17, 2009
Test Your Knowledge Issue 457
Posted February 24, 2009
Discovery of a New Receptor Antagonist Predicts Diabetes 2 Onset
Posted April 18, 2009
A Spoonful of Vinegar Helps the Sugar Go Down
Posted February 08, 2005
Letter From The Editor. June 29, 2009 Issue #475
Posted June 29, 2009
Artificial Sweeteners Linked to Two-Fold Increase in Diabetes
Posted June 23, 2009
Lantus Insulin: A Possible Link with Cancer - Requires Further Investigation
Posted June 29, 2009

See more most read...


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Marilyn Porter, RD, CDE | Melissa Diane Smith | Paul Chous, M.A., OD | Philip A. Wood PhD | Sheri R. Colberg PhD | Sherri Shafer | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
Diabetes In Control Advertisers
Cast Your Vote
What percent of your Type 2 patients are on oral triple therapy and have an A1c below 6.4%?
Featured Jobs
CME/CE of the Week
Category: Nutrition
CE Credits: .75
 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Sponsored Link


Advertisement


Advertisement




Search Articles On Diabetes In Control